World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 2808627

Number of visits today: 549

Number of downloads: 2060627

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Li H, Xiao W, He Y, Wen Z, Cheng S, Zhang Y, Li Y. Novel Insights Into the Multifaceted Functions of RNA n⁶-Methyladenosine Modification in Degenerative Musculoskeletal Diseases. Front Cell Dev Biol 2021;9:766020. [PMID: 35024366 DOI: 10.3389/fcell.2021.766020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]

For:

Li H, Xiao W, He Y, Wen Z, Cheng S, Zhang Y, Li Y. Novel Insights Into the Multifaceted Functions of RNA n⁶-Methyladenosine Modification in Degenerative Musculoskeletal Diseases. Front Cell Dev Biol 2021;9:766020. [PMID: 35024366 DOI: 10.3389/fcell.2021.766020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]

Number	Citing Articles
1	Li Z, Meng X, Chen Y, Xu X, Guo J. N(6)-methyladenosine (m(6)A) writer METTL3 accelerates the apoptosis of vascular endothelial cells in high glucose. Heliyon 2023;9:e13721. [PMID: 36873555 DOI: 10.1016/j.heliyon.2023.e13721] [Reference Citation Analysis]
2	Yuan B, Zhou J. N(6)-methyladenosine (m(6)A) reader IGF2BP1 facilitates clear-cell renal cell carcinoma aerobic glycolysis. PeerJ 2023;11:e14591. [PMID: 36691477 DOI: 10.7717/peerj.14591] [Reference Citation Analysis]
3	Cui Y, Liu J, Liu L, Ma X, Gui Y, Liu H, Zhao W. m(6)A-modified circFOXK2 targets GLUT1 to accelerate oral squamous cell carcinoma aerobic glycolysis. Cancer Gene Ther 2023;30:163-71. [PMID: 36127411 DOI: 10.1038/s41417-022-00526-6] [Reference Citation Analysis]
4	Ouyang Y, Tu Y, Chen S, Min H, Wen Z, Zheng G, Wan T, Fan H, Yang W, Sun G. Characterization of immune microenvironment infiltration and m(6)A regulator-mediated RNA methylation modification patterns in osteoarthritis. Front Immunol 2022;13:1018701. [PMID: 36505479 DOI: 10.3389/fimmu.2022.1018701] [Reference Citation Analysis]
5	Liu H, Zheng Y, Wang X. The emerging roles of N6-methyladenosine in osteoarthritis. Front Mol Neurosci 2022;15. [DOI: 10.3389/fnmol.2022.1040699] [Reference Citation Analysis]
6	Tang B, Li M, Xu Y, Li X. N6-methyladenosine (m6A) writer KIAA1429 accelerates gastric cancer oxaliplatin chemoresistance by targeting FOXM1. J Cancer Res Clin Oncol 2022. [DOI: 10.1007/s00432-022-04426-y] [Reference Citation Analysis]
7	Li Z, Meng X, Chen Y, Xu X, Guo J. N6-methyladenosine (m6A) writer METTL3 accelerates the apoptosis of vascular endothelial cells in high glucose.. [DOI: 10.21203/rs.3.rs-1981358/v1] [Reference Citation Analysis]
8	Yuan B, Zhou J. N6-methyladenosine (m6A) reader IGF2BP1 facilitates clear-cell renal cell carcinoma aerobic glycolysis.. [DOI: 10.21203/rs.3.rs-1959363/v1] [Reference Citation Analysis]
9	Zhai G, Xiao L, Jiang C, Yue S, Zhang M, zheng J, Liu Z, Dong Y. Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis. Front Cell Dev Biol 2022;10:946219. [DOI: 10.3389/fcell.2022.946219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10	Xu K, Dai X, Wu J, Wen K. N⁶-methyladenosine (m⁶A) reader IGF2BP2 stabilizes HK2 stability to accelerate the Warburg effect of oral squamous cell carcinoma progression. J Cancer Res Clin Oncol 2022. [PMID: 35763110 DOI: 10.1007/s00432-022-04093-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11	Fang S, Zeng F, Chen R, Li M. SIAH1 promotes senescence and apoptosis of nucleus pulposus cells to exacerbate disc degeneration through ubiquitinating XIAP. Tissue Cell 2022;76:101820. [PMID: 35580525 DOI: 10.1016/j.tice.2022.101820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]